Moloney Securities Asset Management LLC Purchases 5,533 Shares of CVS Health Corporation (NYSE:CVS)

Moloney Securities Asset Management LLC raised its position in CVS Health Corporation (NYSE:CVS - Free Report) by 20.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,838 shares of the pharmacy operator's stock after purchasing an additional 5,533 shares during the period. Moloney Securities Asset Management LLC's holdings in CVS Health were worth $2,225,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Hopwood Financial Services Inc. acquired a new stake in shares of CVS Health during the fourth quarter worth $29,000. McIlrath & Eck LLC boosted its position in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the period. Sierra Ocean LLC grew its holdings in shares of CVS Health by 584.8% during the first quarter. Sierra Ocean LLC now owns 719 shares of the pharmacy operator's stock worth $49,000 after buying an additional 614 shares in the last quarter. MV Capital Management Inc. lifted its stake in CVS Health by 63.9% in the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock valued at $50,000 after acquiring an additional 289 shares in the last quarter. Finally, Dunhill Financial LLC boosted its position in CVS Health by 147.2% during the 1st quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock worth $51,000 after acquiring an additional 446 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Barclays set a $79.00 price target on CVS Health and gave the company an "overweight" rating in a research note on Monday, June 2nd. UBS Group raised their target price on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Cowen reissued a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Truist Financial lifted their target price on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Finally, Piper Sandler lifted their price objective on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research report on Friday, March 21st. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $75.06.

CVS Health Trading Down 1.4%

NYSE:CVS traded down $0.89 on Friday, reaching $64.73. 7,020,831 shares of the stock traded hands, compared to its average volume of 10,783,052. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The company's 50 day moving average is $65.10 and its 200-day moving average is $62.08. The firm has a market capitalization of $81.88 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 0.95 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. The business's revenue was up 7.0% on a year-over-year basis. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.11%. CVS Health's dividend payout ratio (DPR) is currently 63.48%.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.22% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.